Settlement may compensate consumers who bought Robitussin cough medicine products that were falsely marketed as "non-drowsy." ...

Consumers who bought a popular cough syrup could be eligible for money as part of a class action settlement. Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the ...

In the US, the maker of Robitussin cough syrup is recalling several products containing honey due to contamination. If you're someone reaching for cough syrups reguarly during cold spells you're ...

Anyone in the U.S. who bought any flavor Robitussin product containing dextromethorphan (or DXM) and labeled as “non-drowsy” between Feb. 16, 2016, and Jan. 21 are eligible to file a claim, according ...

Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US ...